Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Amir H Taghinia, M.D.

Co-Author

This page shows the publications co-authored by Amir Taghinia and John Mulliken.
Connection Strength

0.454
  1. A case of Proteus syndrome with lateral embryonal vein and frontal intraosseous lipoma. Cleft Palate Craniofac J. 2007 Sep; 44(5):567-71.
    View in: PubMed
    Score: 0.095
  2. Diffuse Venous Malformations of the Upper Extremity (Bockenheimer Disease): Diagnosis and Management. Plast Reconstr Surg. 2020 12; 146(6):1317-1324.
    View in: PubMed
    Score: 0.059
  3. Diffuse Venous Malformations of the Upper Extremity (Bockenheimer disease): Diagnosis and Management. Plast Reconstr Surg. 2020 Sep 07.
    View in: PubMed
    Score: 0.058
  4. Congenital Disseminated Pyogenic Granuloma: Characterization of an Aggressive Multisystemic Disorder. J Pediatr. 2020 Jul 02.
    View in: PubMed
    Score: 0.058
  5. Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations. Angiogenesis. 2019 11; 22(4):547-552.
    View in: PubMed
    Score: 0.054
  6. Fibroadipose Vascular Anomaly in the Upper Extremity: A Distinct Entity With Characteristic Clinical, Radiological, and Histopathological Findings. J Hand Surg Am. 2020 Jan; 45(1):68.e1-68.e13.
    View in: PubMed
    Score: 0.054
  7. A somatic MAP3K3 mutation is associated with verrucous venous malformation. Am J Hum Genet. 2015 Mar 05; 96(3):480-6.
    View in: PubMed
    Score: 0.040
  8. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity. J Pediatr Orthop. 2014 Jan; 34(1):109-17.
    View in: PubMed
    Score: 0.037
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.